ZA952243B - Recombinant viruses their preparation and their use in gene therapy - Google Patents
Recombinant viruses their preparation and their use in gene therapyInfo
- Publication number
- ZA952243B ZA952243B ZA952243A ZA952243A ZA952243B ZA 952243 B ZA952243 B ZA 952243B ZA 952243 A ZA952243 A ZA 952243A ZA 952243 A ZA952243 A ZA 952243A ZA 952243 B ZA952243 B ZA 952243B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- gene therapy
- recombinant viruses
- viruses
- recombinant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Marine Sciences & Fisheries (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9403192A FR2717497B1 (en) | 1994-03-18 | 1994-03-18 | Recombinant viruses, preparation and use in gene therapy. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA952243B true ZA952243B (en) | 1996-01-09 |
Family
ID=9461191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA952243A ZA952243B (en) | 1994-03-18 | 1995-03-17 | Recombinant viruses their preparation and their use in gene therapy |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0750674A1 (en) |
JP (1) | JPH09510356A (en) |
AU (1) | AU1896095A (en) |
CA (1) | CA2184408A1 (en) |
FR (1) | FR2717497B1 (en) |
IL (1) | IL112994A0 (en) |
WO (1) | WO1995025802A1 (en) |
ZA (1) | ZA952243B (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5270452A (en) * | 1988-11-28 | 1993-12-14 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Pure glia maturation factor |
FR2688514A1 (en) * | 1992-03-16 | 1993-09-17 | Centre Nat Rech Scient | Defective recombinant adenoviruses expressing cytokines and antitumour drugs containing them |
WO1994008026A1 (en) * | 1992-09-25 | 1994-04-14 | Rhone-Poulenc Rorer S.A. | Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
FR2704234B1 (en) * | 1993-04-22 | 1995-07-21 | Centre Nat Rech Scient | RECOMBINANT VIRUSES, PREPARATION AND USE IN GENE THERAPY. |
-
1994
- 1994-03-18 FR FR9403192A patent/FR2717497B1/en not_active Expired - Fee Related
-
1995
- 1995-03-02 CA CA002184408A patent/CA2184408A1/en not_active Abandoned
- 1995-03-02 AU AU18960/95A patent/AU1896095A/en not_active Abandoned
- 1995-03-02 JP JP7524415A patent/JPH09510356A/en active Pending
- 1995-03-02 WO PCT/FR1995/000248 patent/WO1995025802A1/en not_active Application Discontinuation
- 1995-03-02 EP EP95911369A patent/EP0750674A1/en not_active Withdrawn
- 1995-03-14 IL IL11299495A patent/IL112994A0/en unknown
- 1995-03-17 ZA ZA952243A patent/ZA952243B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP0750674A1 (en) | 1997-01-02 |
CA2184408A1 (en) | 1995-09-28 |
FR2717497B1 (en) | 1996-04-12 |
AU1896095A (en) | 1995-10-09 |
WO1995025802A1 (en) | 1995-09-28 |
JPH09510356A (en) | 1997-10-21 |
IL112994A0 (en) | 1995-06-29 |
FR2717497A1 (en) | 1995-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA949104B (en) | Recombinant viruses and their use in gene therapy | |
ZA951803B (en) | Recombinant viruses their preparation and their therapeutic use | |
ZA952563B (en) | Recombinant viruses their preparation and their use in gene therapy | |
IL115584A0 (en) | Viral vectors and their use in gene therapy | |
AU4032893A (en) | Human papilloma virus genes and their use in gene therapy | |
ZA945012B (en) | Viral vectors and their use in gene therapy | |
IL113844A (en) | N-(alpha-ETHYLBENZYL)-3-HYDROXY-2-PHENYLQUINOLINE-4-CARBOXAMIDE AND ITS USE IN THE PREPARATION OF MEDICAMENTS | |
HUP9801216A3 (en) | Dna molecules, preparation thereof and use thereof in gene therapy | |
HU9503751D0 (en) | Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection | |
SG54275A1 (en) | Dna coding for decarbamylase improved in thermostability and use thereof | |
ZA949103B (en) | Recombinant viruses and their use in gene therapy | |
EP0752472A4 (en) | Novel gene originating in corynebacterium and use thereof | |
ZA956849B (en) | Use of a defective recombinant adenovirus in gene therapy | |
IL117466A0 (en) | Recombinant viruses expressing lecithin-cholesterol acryltransferase and their use in gene therapy | |
GB9419553D0 (en) | Polypeptides and their use in the treatment of auto-immune disease | |
IL112075A0 (en) | Recombinant human thymopoietin proteins, their preparation and their medicinal use | |
ZA952242B (en) | Recombinant viruses their preparation and their use in gene therapy | |
ZA964563B (en) | Isoindole derivatives their preparation and their application in therapy | |
ZA952244B (en) | Recombinant viruses their preparation and their use in gene therapy | |
IL128902A0 (en) | N-(2-benzothiazolyl)-1-piperidineethanamine derivatives their preparation and their use in therapy | |
ZA959904B (en) | Iminooxymethyleneanilides thei preparation and their use | |
FR2725213B1 (en) | VIRAL VECTORS AND USE IN GENE THERAPY | |
IL113725A0 (en) | Preparing recombinant aprotini and its variants | |
ZA952286B (en) | Recombinant viruses their preparation and their use in gene therapy | |
ZA952243B (en) | Recombinant viruses their preparation and their use in gene therapy |